<DOC>
	<DOCNO>NCT02726074</DOCNO>
	<brief_summary>This multi-center , open-label , single-arm , phase 4 study evaluate efficacy perampanel add monotherapy partial onset seizure without secondarily generalize seizure ( total seizure ) .</brief_summary>
	<brief_title>Trial Evaluating Efficacy Safety Perampanel Added Monotherapy Participants With Partial Onset Seizures</brief_title>
	<detailed_description>This multi-center , open-label , single-arm study evaluate efficacy perampanel add monotherapy partial onset seizure consist 2 period : Titration Period ( 12 week ) Maintenance Period ( 24 week ) . During Titration Period , participant begin receive perampanel 2 milligram per day ( mg/day ) up-titrated less 2-week interval increment 2 mg 12 mg accord investigator 's judgment . Upon enter Maintenance Period , participant receive last dose achieve end Titration Period continue receive dose daily remainder study .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Have diagnosis epilepsy partial onset seizure without secondarily generalize seizures accord International League Against Epilepsy 's Classification Epileptic Seizures ( 1981 ) Need initial addon therapy failure control seizures first monotherapy optimal dose duration Despite antiepileptic drug ( AED ) treatment within last 8 week , participant must great equal 2 partial onset seizure , interval seizures 24 hour prior Visit 1 ( Week 0 ) . Are currently treat stable dos monotherapy 8 week prior Visit 1 ( Week 0 ) ( Standard AEDs ) If antidepressant antianxiety drug use , participant must receive stable dos administration antidepressant antianxiety drug 8 week prior Visit 1 ( Week 0 ) Females pregnant ( positive Î²hCG test ) breastfeed Presence previous history LennoxGastaut syndrome Presence nonmotor simple partial seizure Presence primary generalize epilepsy seizure absence and/or myoclonic epilepsy A history status epilepticus within 12 week Visit 1 ( Week 0 ) Participants antipsychotic psychotic disorder ( ) unstable recurrent affective disorder ( ) history attempt suicide within 1 year Visit 1 ( Week 0 ) Presence progressive central nervous system ( CNS ) disease , include degenerative CNS disease progressive tumor Concomitant use barbiturate ( except seizure control indication premedication electroencephalogram [ EEG ] ) benzodiazepine ( except seizure control indication ) within 8 week prior Visit 1 ( Week 0 ) Use intermittent rescue benzodiazepine ( ie , 1 2 dos 24hr period consider onetime rescue ) 2 time 8week period prior Visit 1 ( Week 0 ) Participant participate intervention clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>partial-onset seizure</keyword>
	<keyword>secondarily generalize seizure</keyword>
</DOC>